What is the Need for Prostatic Biomarkers in Prostate Cancer Management?

Discriminating patients with a low risk of progression from those with lethal prostate cancer is one of the main challenges in prostate cancer management. Indeed, such discrimination is essential if we aim to avoid overtreatment in men with indolent disease and to improve survival in those men with...

Descripción completa

Detalles Bibliográficos
Autores principales: Spahn, Martin, Boxler, Silvan, Joniau, Steven, Moschini, Marco, Tombal, Bertrand, Karnes, R. Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Genetics and Microenvironment (X Cathelineau, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534510/
https://www.ncbi.nlm.nih.gov/pubmed/26267226
http://dx.doi.org/10.1007/s11934-015-0545-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534510/
https://www.ncbi.nlm.nih.gov/pubmed/26267226
http://dx.doi.org/10.1007/s11934-015-0545-3

Ejemplares similares